Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis.

Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis.

Saved in:

Bibliographic Details
Main Authors:	Dick Menzies, Andrea Benedetti, Anita Paydar, Sarah Royce, Pai Madhukar, William Burman, Andrew Vernon, Christian Lienhardt
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2009-09-01
Series:	PLoS Medicine
Online Access:	https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1000150&type=printable
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.
by: Dick Menzies, et al.
Published: (2009-09-01)

Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study
by: Sumaiya Khan, et al.
Published: (2024-12-01)

Tuberculosis among health-care workers in low- and middle-income countries: a systematic review.
by: Rajnish Joshi, et al.
Published: (2006-12-01)

EFFECTIVENESS OF COMBINATION OF ISONIAZID AND SILVER NANOPARTICLES IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS
by: A. V. Zаkhаrov, et al.
Published: (2017-06-01)

Is a 6-month Treatment for Isoniazid-resistant Tuberculosis Effective?
by: A. I. Kulizhskaya, et al.
Published: (2022-03-01)

Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment
by: Valentina Gerussi, et al.
Published: (2025-03-01)

Efficacy of Various Approaches to Treatment of Patients with Isoniazid Resistant Pulmonary Tuberculosis
by: I. A. Burmistrova, et al.
Published: (2023-12-01)

The efficacy of the combination drug of hydroxymethylquinoxalinedioxide + isoniazid lyophilisate in the treatment of bronchial tuberculosis
by: A. A. Stаrshinovа
Published: (2019-05-01)

Prevalence of abnormal radiological findings in health care workers with latent tuberculosis infection and correlations with T cell immune response.
by: Rajnish Joshi, et al.
Published: (2007-08-01)

Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis
by: Koleka Mlisana, et al.
Published: (2019-11-01)

Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children
by: Amanda de O. E. Moreira, et al.
Published: (2025-05-01)

Diagnosis of Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis: Current Standards and Challenges
by: Giovanni Battista Migliori, et al.
Published: (2008-01-01)

Relapse of Pulmonary Tuberculosis in Patients with Resistance to Isoniazid
by: I. A. Burmistrova, et al.
Published: (2023-07-01)

Rectal Administration of Rifampicin and Isoniazid Suppositories: An Alternative Approach for the Treatment of Tuberculosis in a Patient with Multiple Comorbidities
by: Ioana Munteanu, et al.
Published: (2025-05-01)

Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens.
by: William J Burman, et al.
Published: (2008-08-01)

Tuberculosis: treatment failure, or failure to treat? Lessons from India and South Africa
by: Nesri Padayatchi, et al.
Published: (2019-02-01)

Differentiated Approaches to Chemotherapy of Respiratory Tuberculosis in Children Exposed to Isoniazid Resistant Tuberculosis
by: M. F. Gubkina, et al.
Published: (2021-09-01)

Pneumonectomy in the treatment of tuberculosis relapse in a previously resected lung
by: D. B. Giller, et al.
Published: (2020-06-01)

Isoniazid-Induced Acute Psychosis in a Patient with Pleural Tuberculosis
by: Joana Gomes, et al.
Published: (2019-01-01)

Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis.
by: Sebastian Gagneux, et al.
Published: (2006-06-01)

Erratum for Prommi et al., “Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand”
by: Ajala Prommi, et al.
Published: (2024-12-01)

Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review.
by: Karen R Steingart, et al.
Published: (2007-06-01)

Treatment outcomes and key factors contributing to unfavourable outcomes among isoniazid-resistant pulmonary tuberculosis patients in Shanghai, China
by: Wenjing Xiao, et al.
Published: (2025-05-01)

One-year mortality of tuberculosis patients on isoniazid-based treatment and its association with rapid acetylator NAT2 genotypes
by: Ayu Kasamatsu, et al.
Published: (2025-06-01)

Completion of tuberculosis preventive treatment with 300 mg vs. 100 mg isoniazid tablets: a pragmatic randomized clinical trial
by: João Paulo Cola, et al.
Published: (2025-03-01)

Case fatality and recurrent tuberculosis among patients managed in the private sector: A cohort study in Patna, India.
by: Sophie Huddart, et al.
Published: (2021-01-01)

REPEATED LUNG RESECTIONS IN THE TREATMENT OF POSTOPERATIVE RECURRENT TUBERCULOSIS OF THE PREVIOUSLY RESECTED LUNG
by: I. B. Murgustov, et al.
Published: (2012-06-01)

Endothelial Dysfunction Markers Correlate with the Time Since Completion of Tuberculosis Treatment and the Number of Previous Tuberculosis Episodes
by: Chrisstoffel Jumaar, et al.
Published: (2025-02-01)

High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
by: Heng Yang, et al.
Published: (2021-01-01)

Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV/AIDS: a systematic review of qualitative data.
by: Titilola Makanjuola, et al.
Published: (2014-01-01)

Clinical Profile and Treatment Outcome of H-mono/Polydrug-resistant Tuberculosis: A Single-center Retrospective Study
by: Shital Kabra, et al.
Published: (2024-11-01)

Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review.
by: Marva Seifert, et al.
Published: (2015-01-01)

Analysis of Isoniazid, Streptomycin and Ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco
by: Imane Chaoui, et al.
Published: (2009-05-01)

Genetic mutations associated with rifampicin and isoniazid resistance in tuberculosis patients in Bhubaneswar, India
by: Dr Sidhartha Giri, et al.
Published: (2025-03-01)

Delayed culture conversion predicts poor outcomes for isoniazid mono-resistant TB in Uganda: a retrospective cross-sectional study from 2017– 2022
by: Joel Kabugo, et al.
Published: (2025-07-01)

Achieving Systemic and Scalable Private Sector Engagement in Tuberculosis Care and Prevention in Asia.
by: William A Wells, et al.
Published: (2015-06-01)

The role of isoniazid dosage and NAT2 gene polymorphism in the treatment of tuberculous meningitis
by: Yi Jian, et al.
Published: (2025-01-01)

The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan.
by: Adel Hussein Elduma, et al.
Published: (2023-01-01)

Tuberculosis case fatality in India: a systematic review and meta-analysis
by: Madhukar Pai, et al.
Published: (2020-01-01)

RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS
by: I. A. Burmistrova, et al.
Published: (2019-01-01)